Surface Oncology

About:

Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.

Website: http://www.surfaceoncology.com

Twitter/X: surfaceoncology

Top Investors: F-Prime Capital, New Enterprise Associates, Biotechnology Value Fund, Venrock Healthcare Capital Partners, Atlas Venture

Description:

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles in tumor immune evasion.